We salute the U.S. Food and Drug Administration (FDA) for increasing consumer awareness of the ineffectiveness of hyperbaric oxygen therapy (HBOT) as a treatment for autism spectrum disorder (ASD). The FDA released a report on Aug. 22, 2013, stating that “HBOT has not been clinically proven to cure or be effective in the treatment of autism, cancer, or diabetes, nor has it been approved by FDA.”
- How Cool Are These? We Found 6 Awesome Gadgets for Parents of Children with Special Needs!
- Holly Robinson Peete Opens Up on Autism Live About Motherhood, the Teen Years and the Future of Autism
- CARD to Host Free Colorado Conference to Provide Treatment Solutions to Families Affected by Autism
- CARD Partners with AutismUp to Help Rochester Parents Gain Access to Autism Insurance Coverage